Skip to main content
. 2018 Feb 23;11(2):467–476. doi: 10.1016/j.tranon.2018.02.001

Table 1.

Patient´s Characteristics of 102 Patients Undergoing Radical Cystectomy

Mannheim Cohort
MD Anderson Cohort
P
n or median percentage/range n or median percentage/range
Age, y 66.6 45.4-92.1 67.4 41.0-90.6 0.72
≥75 21 20.6 9 15.7 0.53
<75 81 79.4 48 84.2
Gender
 Male 77 75.5 49 86.0 0.29
 Female 25 24.5 8 14.0
Tumor stage
 pT1 2 2.0 2 3.5 0.51
 pT2 24 23.5 12 21.1
 pT3 56 53.9 35 61.4
 pT4 20 19.6 8 14.0
 CIS 0 0 0 0
 pT4 or pN+ 47 46.1 39 68.4 0.001
Nodal stage
 pN0 65 63.7 22 38.6 0.002
 pN1 12 11.8 9 15.8
 pN2 25 24.5 26 45.6
Grading
 G3 82 80.5 n.a. n.a.
 G2 19 18.6 n.a. n.a.
 G1 1 0.9 n.a. n.a.
 Concomitant carcinoma in situ 23 22.5 n.a. n.a.
Chemotherapy
 Neo-adjuvant 0 0 20 35.0 <0.001
 Adjuvant 12 14.8 n.a. n.a.
Outcome
 Follow-up 20.8 3.6-179.2 38.1 3.9-180 0.63
 Cancer-specific death 50 49.0 17 30.0 0.01
 Time to Cancer-specific death, months 17.6 3.1-86.5 24.2 4.8-79.2 0.17